Correlation Between Spyre Therapeutics and 629377CH3

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and 629377CH3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and 629377CH3 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and NRG Energy 525, you can compare the effects of market volatilities on Spyre Therapeutics and 629377CH3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of 629377CH3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and 629377CH3.

Diversification Opportunities for Spyre Therapeutics and 629377CH3

0.53

Correlation Coefficient

Spyre Therapeutics  629377CH3

Very weak diversification

The 3 months correlation between Spyre and 629377CH3 is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and NRG Energy 525 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRG Energy 525 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with 629377CH3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRG Energy 525 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and 629377CH3 go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and 629377CH3

Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 4.07 times more return on investment than 629377CH3. However, Spyre Therapeutics is 4.07 times more volatile than NRG Energy 525. It trades about -0.03 of its potential returns per unit of risk. NRG Energy 525 is currently generating about -0.15 per unit of risk. If you would invest  2,750  in Spyre Therapeutics on October 6, 2024 and sell it today you would lose (315.00) from holding Spyre Therapeutics or give up 11.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	96.77%
Values	Daily Returns

Spyre Therapeutics  vs.  NRG Energy 525

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

NRG Energy 525

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NRG Energy 525 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for NRG Energy 525 investors.

Pair Trading with Spyre Therapeutics and 629377CH3

The main advantage of trading using opposite Spyre Therapeutics and 629377CH3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, 629377CH3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 629377CH3 will offset losses from the drop in 629377CH3's long position.

The idea behind Spyre Therapeutics and NRG Energy 525 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..